All evidence indicates that this crossing does not affect either the sleep or AD phenotypes described for the original lines: AP+ mice showed age-dependent accumulation of amyloid plaques, the baseline sleep–wake phenotypes are similar to those previously described in the literature in APP/PS1 mice, and PZGABA seems to not be affected by amyloid burden. Here, PSEN1 is linked to amyloidosis.